Joshua Dennerlein
Stock Analyst at B of A Securities
(2.23)
# 2,739
Out of 4,918 analysts
96
Total ratings
46.15%
Success rate
-3.79%
Average return
Main Sectors:
Stocks Rated by Joshua Dennerlein
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NTST NETSTREIT | Upgrades: Neutral | $18 → $19 | $18.32 | +3.71% | 3 | Jul 28, 2025 | |
FVR FrontView REIT | Downgrades: Underperform | $15 → $11 | $11.34 | -2.96% | 2 | Jun 17, 2025 | |
SUI Sun Communities | Maintains: Underperform | $124 → $132 | $124.38 | +6.13% | 3 | May 12, 2025 | |
TRI Thomson Reuters | Reinstates: Neutral | $180 | $201.15 | -10.51% | 1 | Apr 10, 2025 | |
CTAS Cintas | Reinstates: Buy | $250 | $221.50 | +12.87% | 1 | Apr 10, 2025 | |
MSCI MSCI Inc. | Initiates: Neutral | $585 | $557.40 | +4.95% | 1 | Apr 10, 2025 | |
VRSK Verisk Analytics | Reinstates: Underperform | $280 | $271.89 | +2.98% | 1 | Apr 10, 2025 | |
WELL Welltower | Maintains: Buy | $221 → $242 | $166.24 | +45.57% | 7 | Feb 18, 2025 | |
GTY Getty Realty | Upgrades: Buy | $31 → $34 | $28.04 | +21.26% | 3 | Oct 21, 2024 | |
AHR American Healthcare REIT | Maintains: Buy | $27 → $31 | $38.89 | -20.29% | 2 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $92 | $71.28 | +29.07% | 1 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $307 → $321 | $256.92 | +24.94% | 3 | Sep 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $42.36 | +136.10% | 1 | Aug 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $111 → $147 | $106.95 | +37.45% | 4 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $144 → $189 | $140.00 | +35.00% | 3 | Aug 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $45 → $40 | $55.01 | -27.29% | 4 | May 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $18 → $25 | $16.77 | +49.08% | 2 | Apr 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $33 → $31 | $39.95 | -22.40% | 11 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $53 | $67.50 | -21.48% | 9 | Jan 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 → $6 | $7.24 | -17.13% | 1 | Nov 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $42 → $33 | $38.74 | -14.81% | 1 | Oct 31, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $52 | $56.57 | -8.08% | 1 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $18.30 | - | 4 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $67 → $54 | $64.98 | -16.90% | 4 | Sep 26, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $8 | $4.06 | +97.04% | 9 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $27 | $13.61 | +98.38% | 1 | Jun 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $34 | $15.73 | +112.97% | 5 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $30.54 | - | 4 | Aug 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 → $78 | $73.73 | +5.79% | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $47 | $42.02 | +11.85% | 2 | Jan 20, 2022 |
NETSTREIT
Jul 28, 2025
Upgrades: Neutral
Price Target: $18 → $19
Current: $18.32
Upside: +3.71%
FrontView REIT
Jun 17, 2025
Downgrades: Underperform
Price Target: $15 → $11
Current: $11.34
Upside: -2.96%
Sun Communities
May 12, 2025
Maintains: Underperform
Price Target: $124 → $132
Current: $124.38
Upside: +6.13%
Thomson Reuters
Apr 10, 2025
Reinstates: Neutral
Price Target: $180
Current: $201.15
Upside: -10.51%
Cintas
Apr 10, 2025
Reinstates: Buy
Price Target: $250
Current: $221.50
Upside: +12.87%
MSCI Inc.
Apr 10, 2025
Initiates: Neutral
Price Target: $585
Current: $557.40
Upside: +4.95%
Verisk Analytics
Apr 10, 2025
Reinstates: Underperform
Price Target: $280
Current: $271.89
Upside: +2.98%
Welltower
Feb 18, 2025
Maintains: Buy
Price Target: $221 → $242
Current: $166.24
Upside: +45.57%
Getty Realty
Oct 21, 2024
Upgrades: Buy
Price Target: $31 → $34
Current: $28.04
Upside: +21.26%
American Healthcare REIT
Sep 24, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $38.89
Upside: -20.29%
Sep 24, 2024
Initiates: Buy
Price Target: $92
Current: $71.28
Upside: +29.07%
Sep 24, 2024
Downgrades: Neutral
Price Target: $307 → $321
Current: $256.92
Upside: +24.94%
Aug 19, 2024
Initiates: Buy
Price Target: $100
Current: $42.36
Upside: +136.10%
Aug 12, 2024
Upgrades: Buy
Price Target: $111 → $147
Current: $106.95
Upside: +37.45%
Aug 12, 2024
Upgrades: Buy
Price Target: $144 → $189
Current: $140.00
Upside: +35.00%
May 20, 2024
Downgrades: Underperform
Price Target: $45 → $40
Current: $55.01
Upside: -27.29%
Apr 1, 2024
Upgrades: Buy
Price Target: $18 → $25
Current: $16.77
Upside: +49.08%
Jan 16, 2024
Downgrades: Neutral
Price Target: $33 → $31
Current: $39.95
Upside: -22.40%
Jan 16, 2024
Upgrades: Buy
Price Target: $48 → $53
Current: $67.50
Upside: -21.48%
Nov 7, 2023
Downgrades: Underperform
Price Target: $18 → $6
Current: $7.24
Upside: -17.13%
Oct 31, 2023
Downgrades: Neutral
Price Target: $42 → $33
Current: $38.74
Upside: -14.81%
Oct 10, 2023
Downgrades: Neutral
Price Target: $52
Current: $56.57
Upside: -8.08%
Oct 10, 2023
Upgrades: Buy
Price Target: n/a
Current: $18.30
Upside: -
Sep 26, 2023
Maintains: Underperform
Price Target: $67 → $54
Current: $64.98
Upside: -16.90%
Aug 11, 2023
Downgrades: Underperform
Price Target: $9 → $8
Current: $4.06
Upside: +97.04%
Jun 13, 2023
Initiates: Underperform
Price Target: $27
Current: $13.61
Upside: +98.38%
Nov 14, 2022
Upgrades: Buy
Price Target: $28 → $34
Current: $15.73
Upside: +112.97%
Aug 24, 2022
Upgrades: Buy
Price Target: n/a
Current: $30.54
Upside: -
Jun 2, 2022
Upgrades: Buy
Price Target: $76 → $78
Current: $73.73
Upside: +5.79%
Jan 20, 2022
Downgrades: Underperform
Price Target: $52 → $47
Current: $42.02
Upside: +11.85%